: Liver transplant (LT) recipients are considered at a particularly high risk for developing critical COVID-19 infection. To date, available data are heterogeneous and scarce and mortality in LT recipients seems to be higher compared to normal population, but whether this is caused by altered immunological status, immunosuppression (IS), or underlying comorbidities has not yet been fully clarified. Some evidences show that IS might play a role in the pathophysiology of this new disease. We searched all available data regarding LT recipients infected by COVID-19, focusing on the role of IS. To date, 244 LT recipients have been reported as COVID-19-positive. Trends among transplant physicians are to reduce overall IS, especially antimetabolite drugs, but the current available observations are still not enough to build strong evidences for recommendation and IS should be meticulously tailored case by case.

Parente, A., Manzia, T.m., Angelico, R., Tirotta, F., Muiesan, P., Tisone, G., et al. (2021). COVID-19, liver transplant, and immunosuppression: Allies or foes?. TRANSPLANT INFECTIOUS DISEASE, 23(1) [10.1111/tid.13417].

COVID-19, liver transplant, and immunosuppression: Allies or foes?

Manzia T. M.;Angelico R.;Tisone G.;
2021-01-01

Abstract

: Liver transplant (LT) recipients are considered at a particularly high risk for developing critical COVID-19 infection. To date, available data are heterogeneous and scarce and mortality in LT recipients seems to be higher compared to normal population, but whether this is caused by altered immunological status, immunosuppression (IS), or underlying comorbidities has not yet been fully clarified. Some evidences show that IS might play a role in the pathophysiology of this new disease. We searched all available data regarding LT recipients infected by COVID-19, focusing on the role of IS. To date, 244 LT recipients have been reported as COVID-19-positive. Trends among transplant physicians are to reduce overall IS, especially antimetabolite drugs, but the current available observations are still not enough to build strong evidences for recommendation and IS should be meticulously tailored case by case.
2021
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/18 - CHIRURGIA GENERALE
English
COVID-19
liver transplant
liver transplantation
Parente, A., Manzia, T.m., Angelico, R., Tirotta, F., Muiesan, P., Tisone, G., et al. (2021). COVID-19, liver transplant, and immunosuppression: Allies or foes?. TRANSPLANT INFECTIOUS DISEASE, 23(1) [10.1111/tid.13417].
Parente, A; Manzia, Tm; Angelico, R; Tirotta, F; Muiesan, P; Tisone, G; Framarino dei Malatesta, M
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/314166
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 9
social impact